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Abstract
Background: Rapid diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) have been widely
advocated by government and the international community as cost-effective tools for diagnosis and treatment of
malaria. ACTs are now the first line treatment drug for malaria in Nigeria and RDTs have been introduced by the
government to bridge the existing gaps in proper diagnosis. However, it is not known how readily available these
RDTs and ACTs are in public and private health facilities and whether health workers are actually using them.
Hence, this study investigated the levels of availability and use of RDTs and ACTs in these facilities.
Methods: The study was undertaken in Enugu state, southeast Nigeria in March 2009. Data was collected from
heads of 74 public and private health facilities on the availability and use of RDTs and ACTs. Also, the availability of
RDTs and the types of ACTs that were available in the facilities were documented.
Results: Only 31.1% of the health facilities used RDTs to diagnose malaria. The majority used the syndromic
approach. However, 61.1% of healthcare providers were aware of RDTs. RDTs were available in 53.3% of the
facilities. Public health facilities and health facilities in the urban areas were using RDTs more and these were
mainly bought from pharmacy shops and supplied by NGOs. The main reasons given for non use are unreliability
of RDTs, supply issues, costs, preference for other methods of diagnosis and providers’ ignorance. ACTs were the
drug of choice for most public health facilities and the drugs were readily available in these facilities.
Conclusion: Although many providers were knowledgeable about RDTs, not many facilities used it. ACTS were
readily available and used in public but not private health facilities. However, the reported use of ACTs with limited
proper diagnosis implies that there could be high incidence of inappropriate case management of malaria which
can also increase the economic burden of illnesses. Government and donors should ensure constant availability of
RDTs in both public and private facilities, so that every treatment with ACTs is accompanied with proper diagnosis.
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Background
Malaria remains a public health problem. Worldwide, it
is estimated that around 350-500 million clinical malaria
disease episodes occur annually [1]. Estimates show that
nearly 60% of the cases of clinical malaria and 700,000
to 1.3 million deaths attributable to malaria (over 90%)
occur in sub-Saharan Africa [1]. Nigeria is known for
high prevalence of malaria [2,3] and accounts for a
quarter of all malaria cases in the WHO African region
[4]. It is a leading cause of morbidity and mortality in
the country [3]. Available records show that at least 50%
of the population of the country suffers from at least
one episode of clinical malaria each year and it accounts
for over 45% of outpatient visits, 25 and 30% of infant
and childhood deaths, respectively and 11% of maternal
mortality [3]. In addition, about 12% of gross domestic
product is lost to malaria in Nigeria [5].
Prompt and accurate diagnosis of malaria is part of
effective disease management and the diagnostic
approaches most commonly used are based on the
symptoms and signs of the disease and microscopic
diagnosis. All these methods have their disadvantages
[6-8] which have favoured the introduction and use of
rapid diagnostic tests (RDTs).
In Nigeria, Parasight TML ICT and OptiMAL became
commercially available in 2000. More recently, others
like SD Biolin were also introduced into the Nigerian
market. Studies to evaluate the efficacy of these RDTs in
Nigeria [9-11] have reported efficacy similar to expert
microscopy. In addition, RDTs have been shown to be
cost effective in treating malaria in Nigeria [12] and
potentially saves the cost and time wasted on presump-
tive treatment [9].
Presently, over 30 different RDTs brands exist and
about 25 million were procured worldwide in 2005 [13].
However, these different brands have different sensitivity
and specificity and heat-stability has been a major con-
cern for some especially under field conditions [14].
Also, RDT sensitivity has been shown to depend greatly
on user ability to correctly prepare and carry out the
test and interpret the results [15,16].
The introduction of RDTs have become a crucial
component of malaria control because of the higher-
priced artemisinin-based combination therapy (ACT),
which was introduced in Nigeria in 2005 as the first-line
anti-malarial drug [3], as a result of extensive resistance
to chloroquine and sulphadoxine-pyrimethamine (SP).
In addition, WHO recommended that combination of
antimalarials be used to treat malaria caused by P. falci-
parum [17], and that laboratory diagnosis be done
before patients are treated with ACT [18].
Both RDTs and ACTs therefore are an intrinsic part
of the Nigerian malaria control armamentarium.
However, the availability of such a test and drug in
health care facilities in Nigeria is not known. Hence, it
is vital to determine whether both are available and
provided by health facilities and to understand con-
straints in availability and use. This study therefore set
out to document the methods of diagnosis of malaria
in public and private health facilities and the availabil-
ity and utilization of RDTs and ACTs in the diagnosis
and treatment of malaria in health facilities in Enugu
State. The paper contributes to the evidence on the




The study was carried out in Enugu State in south east-
ern Nigeria. It has a total of 17 local government areas
(LGAs) out of which 4 are urban while 13 are rural.
The State operates a district health system (DHS) which
is different from what obtains in other parts of the
country, with each district serving a population size
varying from 160,000-600,000 people [19]. Malaria is
holo-endemic in the rural areas and meso-endemic in
the urban areas.
Study Design
This was a descriptive cross sectional study involving
public and private healthcare facilities in urban and
rural Enugu state. The study was conducted in March
2009
Sampling
From a sample frame of 4 urban LGAs, Enugu North
was chosen by simple random sampling and from a
sample frame of 13 rural LGAs, Nkanu East was chosen
by simple random sampling. In these two LGAs, all the
health facilities, both private and public, were recruited
for the study. Overall, there were 21 public health facil-
ities and 70 private health facilities in Enugu North
(Urban) giving a total of 91 health facilities. There were
26 public health facilities and 10 private health facilities
in Nkanu East (rural) giving a total of 36 health facil-
ities. Of all these only 110 are functional and only 82
facilities treat malaria and were issued questionnaires,
while 28 fell into such categories as dental, optic, ortho-
paedic and other specialized care facilities. Therefore the
total number of health facilities issued questionnaires
was 82; These were the sample units while the study
subjects were the heads of the facilities. The health facil-
ities were stratified into public health facilities (health
centers, district hospitals, and teaching hospital) and pri-
vate health facilities. Figure 1 shows the sampling of the
facilities. The average number of health workers treating
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malaria in the health centers and private clinics is 4, in
the secondary health facility it is 10 and 15 in the ter-
tiary hospital. Only one person per health facility was
interviewed.
Data Collection
Using self-administered questionnaires information was
collected from heads of 82 health establishments-
primary, secondary, tertiary and private- within the
area under study. Each questionnaire was made up of
5 sections:
• socio-demographic characterization of the
respondents,
• knowledge and utilization of RDTs;
• effectiveness, reliability and comparative accuracy
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Figure 1 Flow chart of the sampling method.
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• acquisition/availability supply and economics of
RDTs, quality assurance for the RDTs;
• modes by which malaria is diagnosed in the differ-
ent health facilities, including the costs of the
diagnoses.
In addition, using a checklist availability and brand of
RDTs and the types of ACTs available in the facilities
were noted. The health workers were allowed multiple
responses when they were responding to the question
on the mode of diagnosis they ever used.
Data Analysis
The data was analysed for aggregated data from the pri-
vate and public health facilities using SPSS and EpiInfo
software packages. The main influences on availability
and use of RDTs and ACTs were evaluated through
quantitative analysis of the provider questionnaire
responses. As appropriate, chi-square test was used for
tests of significance for proportions of categorical vari-
ables All tests of significance were done based on a
p-level of 0.05.
Ethical aspects
This research was approved by the College of Medicine,
University of Nigeria Enugu-campus Research Ethics
Committee. Individual informed consent was obtained
from all participants following a verbal and written
explanation of study aims and procedures.
Results
Characteristics of respondents
Seventy-four facilities correctly filled out and returned
their questionnaires given a response rate of 90.2%.
More than half 50 (67.6%) of the functional facilities
were in the urban area. As shown in table 1, among the
doctors and nurses, a majority 22 (95.6%) and 10
(83.3%) respectively were in the urban area, while
among the community health extension workers
(CHEWs)/community health officers (CHO), a majority
20 (90.9%) were in the rural areas.
Methods of malaria diagnosis
Respondents were asked to state the various methods
they used in diagnosing malaria. If they used more than
one method, they were asked to say so. As shown in
table 2, the most common method for diagnosing
malaria in the study area by health workers was syndro-
mic approach, followed by microscopy and then RDT
examination. Doctors and laboratory technicians were
significantly more likely to use RDTs than CHEWs/
CHOs and nurses while the laboratory technicians and
nurses were more likely to use microscopy than doctors
and CHEWs/CHOs. Also, nurses, CHEW/CHO and
Table 1 Socio-demographic characteristics of the
respondents






Doctors 22 (78.3) 1 (21.7) 23 (100)
Nurses 10 (83.3) 2 (16.7) 12 (100)
CHEW/CHO 2 (9.1) 20 (90.9) 22 (100)
Laboratory technologists 16 (94.1) 1 (5.9) 17 (100)
Total 50 (67.6) 24 (32.4) 74 (100)












Doctor (n - 23) 11 (47.8) 10 (43.5) 18 (78.3)
Nurse (n = 12) 0 (0.0) 7 (58.3) 12 (100)
CHEW/CHO (n = 22) 5 (22.7) 0 (0.0) 20 (90.9)
Laboratory Technician
(= 17)
7 (41.2) 12 (70.6) 2 (11.8)





Total (n = 74) 23 (31.1) 29 (39.2) 52 (70.0)
Table 3 Awareness of RDTs among respondents
Awareness of RDT N (%)
Cadre of health worker
Doctors (n = 23) 18 (78.3)
Nurses (n = 12) 3 (25.0)
CHEW/CHO (n = 22) 10 (45.5)




Urban (n = 50) 34 (68.0)
Rural (n = 24) 11 (45.8)
Chi-square 3.34
P-value 0.067






Public (n = 36) 26 (72.2)
Private (n = 38) 19 (50.0)
Chi-square 3.83
P-value 0.05
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doctors were significantly more likely to use syndromic
approach than laboratory technicians. Within the
groups, all the other health workers were significantly
more likely to use syndromic approach except for the
laboratory technicians who used microscopy more.
Knowledge of RDTs
As shown in table 3, majority of the respondents 45/74
(61.1%) knew about RDTs and most of them learnt it
through their co-workers 18 (40%) and conferences 13
(28.9%). Awareness was higher among doctors 18/23
(78.3%) and laboratory technicians 14/17 (82.4%). There
was statistically significant differences in awareness
among the different cadres of health workers. Also, the
proportion of workers aware was higher in the urban
area (34/50, 68.0%) than in the rural area (11/24, 45.8%).
Health workers in the public facilities were more aware
than those in the private facilities and this was statisti-
cally significant.
Availability of RDTs
As shown in table 4, a total of 24 (32.4%) had RDT kits
in their health facilities of work at the time of the sur-
vey. In the urban area, 13/50 (26.0%) of them and 11/24
(45.8%) of the rural facilities had RDTs, but there was
no statistical significant difference (p > 0.05). Among
the public health facilities, 14/36 (38.9%) of them and
10/38 (26.3%) of the private facilities had RDTs, but the
difference was not significant (p > 0.05). Most of these
RDTs were either bought from a pharmacy store 10
(41.7%) or were donated to them by nongovernmental
organizations 10 (41.7%). Only 3 (12.5%) of the facilities
got their RDTs from the government. However 26
(35.1%) of the respondents knew where to purchase or
get RDTs.
Use of RDTs
Table 5 shows that of the 45 that were aware of RDTs,
only 23 (51.1%) facilities had actually used it. Most of
the users were in urban area 16/34 (47.1%) and were
mostly from the public facilities 16/26 (61.5%). Doctors
11/18 (61.1%), laboratory technologists 7/14 (50.0%) and
CHEWs/CHOs 5/10 (50.0%) were the main users with
no nurse using them. Out of the 23 facilities that had
used RDTs only 10 (43.5%) were still using it at the
time of the survey. The non users were mainly from the
private clinics 8/19 (42.1%) and the reasons given for
non use included: unreliability of RDTs, supply issues,
Table 4 Availability of RDT at Respondents’ Place of
Work
Variables N (%)
RDTs availability at place of work (n = 74) 24 (32.4)
Availability in terms of location
Urban (n = 50) 13 (26.0)
Rural (n = 24) 11 (45.8)
Chi-square 2.91
P-value 0.088
Availability in terms of facility
Public (n = 36) 14 (38.9)
Private (n = 38) 10 (26.3)
Chi-square 1.33
P-value 0.248
Sources of RDT (n = 24)
Government 3 (12.5)
Bought from a pharmacy 10 (41.7)
Donated by an NGO 10 (41.7)
Not sure 1 (4.1)
Knowledge of where to get RDT (n = 74) 26 (35.1)
Table 5 Use of RDTs for Diagnosis of Malaria
Variables N (%)
Have Ever Used RDT (n = 45)
Yes 23 (51.1)
No 22 (48.9)
Ever used according to location
Urban (n = 34) 16 (47.1)
Rural (n = 11) 7 (63.6)
Chi-square 0.91
P-value 0.339
Ever used RDTs according to type of facility
Public (n = 26) 16 (61.5)
Private (n = 19) 7 (36.8)
Chi-square 2.68
P-value 0.102
Ever used according to professional cadre
Doctors (n = 18) 11 (61.1)
Nurses (n = 3) 0 (0.0)
CHEW/CHO (n = 10) 5 (50.0)
Laboratory technologists (n = 14) 7 (50.0)
Chi-square 5.99
P-value 0.102
Current usage (n = 23)
Yes 10 (43.5)
No 13 (56.5)
Non usage of RDTs according to facility
Public (n = 26) 5 (19.2)
Private (n = 19) 8 (42.1)
Chi-square 2.8
P-value 0.09
Reasons for non use (n = 13)
Supply issues 4 (30.8)
Not reliable 8 (61.5)
Prefer other methods 2 (15.4)
Cost of RDT 2 (15.4)
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cost of the RDTs and preference for other methods of
diagnosis.
Perception of usefulness of RDT against other diagnostic
methods
Table 6 shows that out of the 23 respondents that had
used RDTs, most of them 17 (74%) said RDTs saved
time and was better than other diagnostic methods 11
(47.8%), while 4 (17.4%) and 2 (8.7%) of them said
RDTs were the same with other diagnostics and were
worse than other diagnostic methods respectively. How-
ever, 6 (26.1%) were not sure. From the table, supply
issues, charge to patients, and ignorance, were the most
important limitations of the use of RDTs being 20
(86.9%), 15 (65.2%) and 6 (26.1%) respectively. More
than 90% of the respondents rated RDTs to be either
good, very good or excellent. A majority of them 16
(69.6%) were satisfied with the benefits of RDT while a
few 3 (13%) and 4 (17.4%) were not and indifferent
respectively.
Knowledge of effect of temperature and humidity on RDT
and RDT preservation at the health facilities
As shown in table 7, of the 23 respondents that had
used RDT, 10/16 (62.5%) in public facilities and 6/7
(85.7%) in private facilities said they knew RDT could
be affected by temperature. While 6/16 (37.5%) and 2/7
(28.6%) of public and private facilities respondents
respectively preserved their RDTs in cold boxes, 4/16
(25.0%) and 2/7 (28.6%) of them in public and private
facilities respectively had no special arrangement. There
was no statistical significant differences between the
private and public facilities in all the variables.
Drug of choice for treatment of malaria and availability of
ACTs in health facilities
Table 8 shows that more of the public health facilities
(32, 88.8%) and fewer (13, 34.2%) of the private health
facilities reported using ACTs for the treatment of
malaria. Private health facilities reported using SP, chlor-
oquine and Artemisinin Monotherapy more than the
public health facilities, being SP (12, 31.6%), chloroquine
(10, 26.3%) and Artemisinin Monotherapy (3, 7.9%) for
private health facilities and SP (2, 5.%6),and chloroquine
(2, 5.6%) for public health facilities respectively.. ACTs
were available in 32 (88.8%) and 17 (44.7%) of the public
and private facilities respectively at the time of this sur-
vey (p < 0.05). Most of the public facilities 30 (83.3%)
and 14 (36.8%) of the private facilities had Artemether-
Lumefantrine (AL). However, Artesunate+Amodiaquine
(AA) were found in 13 (36.1%) of the public and
5 (13.2%) of the private health facilities respectively,
while Dihydroartemisinin-Piperaquine (DP) were found
in 16 (44.4%) of the public and 8 (21.1%) of the private
facilities respectively.




Comparing RDTS with other malarial diagnostic methods
RDTS are worse than other diagnostic methods 2 (8.7)
RDTs are same with other diagnostic methods 4 (17.4)
RDT are better than other diagnostic methods 11 (47.8)
Not sure 6 (26.1)
RDT saves time 17 (74)
Limitations of the use of RDT
Charge to patients 15 (65.2)
Needs special skill 2 (8.7)
Supply issue 20 (86.9)









Not satisfied 3 (13.0)
Indifferent 4 (17.4)









Aware of Effect of Temperature and Humidity on RDT 10 (62.5) 6 (85.7) 1.26 (0.26)
Main method of Preservation of RDT Kits in Health Facilities 4 (25.0) 2 (28.6) 0.03 (0.617)
No special arrangement 3 (18.8) 1 (14.3) 0.07 (0.648)
Cold boxes 6 (37.5) 2 (28.6) 0.17 (0.532)
Moisture-proof envelopes 0 (0.0) 1 (14.3) 2.39 (0.304)
Others 3 (18.8) 1 (14.3) 0.07 (0.648)
Uzochukwu et al. BMC Public Health 2010, 10:486
http://www.biomedcentral.com/1471-2458/10/486
Page 6 of 9
Discussion
Majority of the facilities still use syndromic approach in
the diagnosis of malaria. This finding is not surprising
as this had been previously reported from many ende-
mic countries [6]. Using a syndromic approach in diag-
nosis of malaria means increased likelihood of
unnecessary prescribing of antimalarials [11], because
some other febrile illnesses that are not malaria might
have been treated as malaria. Also the use of, laboratory
diagnosis (RDTs and microscopy) was low in this study.
The low use of microscopy at 39.2% for diagnosis in
this study is similar to the findings of a previous study
in Nigeria where a study based on an audit of 665
patients’ records from public and private hospitals
found that 45% of patients had diagnostic blood slides
[20]. Laboratory diagnosis can improve rational provi-
sion of malaria treatment service as it has been found
that prescribing anti-malarials only after laboratory con-
firmation reduced the total number of prescriptions by
68% in Malawi [21].
The level of awareness of RDTs by all the providers
was not high enough for such an item of enormous uti-
lity as RDTs. This calls for the employment of means of
creating awareness about RDTs among health workers.
If people do not know about a new product and the
likely benefits that could accrue from its use, they are
not likely to use it and this may lead to market failure.
Doctors, CHEWs and laboratory technologists were
more likely to be aware of RDTs than nurses. This is
not unusual for the laboratory technologists since their
main job is to conduct tests. The respondents in urban
areas and in public facilities were more likely to be
aware of RDTs. The reason for this may be that more
attention has been paid to public facilities by govern-
ment and partner agencies in recent times to improve
the case management of malaria in Nigeria.
If more than half of the respondents said RDTs were
ever available at their facility of work, and yet the rate
of use is low, it then becomes a cause for concern and a
threat to the current effort to improve the case manage-
ment of malaria. Some health workers gave the unrelia-
bility of RDTs as a reason for not utilizing available
RDT kits. This suggests they do not trust the results
despite the fact that RDTs have been found to have a
sensitivity of 90.6% and a specificity of 95.9% in Nigeria
[9,10]. It has been noted that health workers still treat
for malaria even when RDT result is negative [22]. How-
ever, most of the health workers who are still using
RDTs tend to be satisfied with the results they get. It is
possible that poor technique, or even poor preservation
of the RDT kits could give rise to poor results which
made some health workers to say they stopped using
RDTs because it was not reliable. Heat-stability has
been noted to be a major concern for some RDTs, espe-
cially under field conditions and the health workers may
have been exposed to different brands of RDTs includ-
ing those with health stability problems [14].
Interestingly, RDTs were more available in the rural
facilities than urban facilities, a finding that favours the
scaling-up of RDTs since a majority of Nigerians live in
rural areas. However, the fact that the government was
the source of RDTs for only 3 facilities is worrisome.
How does W.H.O. intend to promote the RDT use if
the government is obviously lacking any interest? This is
further confirmed by the fact that the source of infor-
mation on RDTs was never through formal training









Drugs used by respondents as first line in the treatment of malaria
Artemisinin-Based Combination Therapy 32 (88.8) 13 (34.2) 23.19 (0.0001)
Sulfadoxine-Pyrimethamine (SP) 2 (5.6) 12 (31.6) 8.16 (0.004)
Chloroquine 2 (5.6) 10 (26.3) 5.86 (0.015)
Artemisinin Monotherapy 0 (0.00) 3 (7.9) 2.96 (0.085)
ACTs available at the time of the survey 32 (88.8) 17 (44.7) 21.29 (0.0001)
Types of ACTs seen in the facility
Artemether-Lumefantrine (AL) 30 (83.3) 14 (36.8) 16.58 (0.0001)
Artesunate+Amodiaquine (AA) 13 (36.1) 5 (13.2) 5.29 (0.021)
Dihydroartemisinin-Piperaquine (DP) 16 (44.4) 8 (21.1) 4.62 (0.032)
Various sources of the ACTs in health facilities
Government 35 (97.2) 9 (23.7) 41.47 (0.0001)
NGO 2 (5.6) 0 (0.0) 2.17 (0.233)F
Purchase from the market 0 (0.0) 26 (68.4) 37.97 (0.0001)
Others 1(2.7) 1(2.6) 0.00 (0.739)F
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sessions promoted by government, as it should be.
Although RDTs are still new in Nigeria and currently
there are no policies in place on its usage in the diagno-
sis of malaria except for that from W.H.O, government
should play a lead role and make RDTs available to
more public facilities.
A majority of the health workers preferred RDTs to
blood film microscopy which is a positive finding as this
will encourage their use of RDTs. Some of the limita-
tions of the use of RDTs as noted by the health workers
included the lack of skills to use it. This is likely to
affect the results of RDTs, a fact that has been raised by
some authors [23,24]. An intervention area to improve
this will be to conduct training and re-training of health
workers on the use of RDTs. A positive finding however,
is that health workers in both public and private facil-
ities know RDT could be affected by temperature and
humidity. This is good for quality control although a
good number in the public facilities are not aware of
this..
The supply of RDT kits to health facilities in Enugu
State has been rather erratic and most RDTs are still
purchased in the open market. This could lead to pur-
chase of fake kits if the market is not properly regulated
as evidence has shown that the drugs in the Nigerian
market may be ineffective, counterfeit or expired [25].
Surprisingly, the drug of choice for the treatment of
uncomplicated malaria in the study areas was ACT.
This is particularly a positive development in the push
to improve the case management of malaria in Nigeria.
However, this finding contrasts with a Nigerian survey
of malaria control practices that showed that less than a
fifth of the primary and secondary health facilities used
the recommended ACT [2] and that monotherapies
such as Chloroquine, SP, Quinine, Artesunate and Dihy-
droartemisinin were still widely used for treatment of
malaria [26].
ACTs especially the recommended first-line types in
the national treatment policy (Artemether-Lumefantrine
(AL) and Artesunate+Amodiaquine (AA) were readily
found in public facilities in diverse trade names. How-
ever, it will be noted that as a matter of policy, ACTs
are supplied free of charge to children who are under 5
years in public health facilities in Enugu, Nigeria [27]
and this may have accounted for the large presence of
ACT in these facilities. The Nigerian malaria control
programme also delivered 4.5 million courses of ACT in
2006 and 9 million in 2007 [4]. ACTs can also be pur-
chased over the counter without a prescription, and can
be dispensed by a non medical personnel. In Nigeria,
pregnant women and children receive free SP and ACTs
respectively from all public health facilities; however this
does not apply to private facilities. In the private sector
charges are fixed by the owners of the facilities while in
government facilities there are often specified fees for
services.
The study shows that ACTs were still not readily
available in private facilities but were more available in
both types of facilities than RDTs. This calls for strate-
gies to ensure that both ACTs and RDTs are made
available to private health care providers at a subsidized
rate in form of public private partnership. But in doing
this, there is need for sustainable monitoring systems as
monitoring and influencing the quality of private ser-
vices is recognized as a key component of effective
malaria treatment [28]
However, the fact that ACTs are readily available (and
not RDTs) and are used and considering the fact that
most health workers still employ syndromic approach
for the diagnosis of malaria, it then means that some
patients will be treated with ACTs without laboratory
diagnosis. Parasitological diagnosis of malaria is an
important parameter leading to the appropriate use of
anti-malarial drugs. Improper and abusive use of ACTs
without proper diagnosis will have a direct clinical and
economic impact [6,29,30]. This therefore calls for inter-
ventions at policy and programmatic levels to improve
treatment provision. And one obvious intervention will
be ensuring that providers stocked adequate doses of
RDTs and ACTs and subsequently used them so as to
decrease unnecessary treatment and reduce societal
costs of malaria.
We did not review the brands of RDTs found in these
facilities and we acknowledge this to be a limitation of
the study. Further studies should audit the type of RDTs
in these facilities as they vary greatly in effectiveness.
The sampled facilities may not be a representative sam-
ple for the whole country and therefore the results may
not be representative of the country. Nevertheless, we
believe that this is a representative sample of all health
facilities in the area of study and the state and therefore
a good starting point in understanding the tremendous
gap existing between the optimal, W.H.O. promoted
policies of RDTs and ACTs and the real application in
practice.
Conclusion
The knowledge of RDTs among health workers is high,
however, it is not readily available. Even among facilities
that once used RDT some have stopped using it mostly
for the reason of perceived reliability, cost and supply
issues. ACTs are readily available in public health facil-
ities but not private health facilities. They are reported
to be used for malaria treatment in the study area. Gov-
ernment and donors should therefore ensure the avail-
ability of RDTs and ACTs in both public and private
facilities. Ensuring the dissemination of information
about the existence, usefulness and proven advantages
Uzochukwu et al. BMC Public Health 2010, 10:486
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of RDT over other methods of diagnosing malaria will
enhance prompt malaria diagnosis and treatment. RDTs
should be provided free of charge or at a subsidized rate
to health facilities to ensure availability the utilization of
RDTs and rational use of ACTs in all health facilities.
This will at the long run facilitate reduction in the bur-
den of malaria.
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